GLUE
Monte Rosa Therapeutics Inc.
$12.85
-$0.16(-1.23%)
67
Overall
60
Value
75
Tech
--
Quality
Market Cap
$767.67M
Volume
1.15M
52W Range
$3.50 - $13.22
Target Price
$16.20
EPS Estimates Overview
| Current Quarter | $-0.39 | Next Quarter | $-0.39 |
| Current Year | $-0.3 | Next Year | $-1.08 |
| QoQ Growth | +0.0% | YoY Growth | -260.0% |
| 3Y EPS CAGR | +30.8% | Target Price | $16.20 |
| Consensus | Buy | Upside | +26.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GLUE | $12.85 | -1.2% | 1.15M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Monte Rosa Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW